Building a National Framework for the Establishment of Regulatory Science for Drug Development: Workshop Summary

by Yeonwoo Lebovitz, Rebecca English, Anne Claiborne

The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the state of regulatory science and to consider approaches for enhancing it.

119 pages, Kindle Edition

First published January 1, 2011